SCHEDULE: FMR LLC Reports 5% Stake in Bio-Techne Corp

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 5.0% of Bio-Techne Corp's common stock as of March 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed a Schedule 13G, indicating beneficial ownership of Bio-Techne Corp's common stock.
• The filing, dated March 31, 2026, reports that FMR LLC beneficially owns 7,859,928.33 shares, representing 5.0% of the class.
• Abigail P. Johnson also beneficially owns 7,859,928.33 shares, also representing 5.0% of the class.
• FMR LLC is identified as an investment adviser (IA) and a parent holding company.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance information for Bio-Techne Corp.

Positives

• FMR LLC, a significant investment management firm, has taken a notable stake in Bio-Techne Corp, potentially signaling confidence in the company's future prospects.
• The reporting persons (FMR LLC and Abigail P. Johnson) hold their shares in the ordinary course of business, suggesting a standard investment approach rather than a hostile takeover intent.

Negatives

• The filing does not contain any negative financial results or operational challenges for Bio-Techne Corp; it is purely an ownership disclosure.

Risks

• While not explicitly stated as risks for Bio-Techne Corp, significant ownership by large institutional investors like FMR LLC can sometimes lead to increased pressure for certain strategic decisions or governance changes.
• The filing does not detail any specific risks related to Bio-Techne Corp's operations or market position.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Bio-Techne Corp's future performance. It is solely an ownership disclosure.

Management Comments

• "This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the 'FMR Reporters')."
• "This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998)."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

StockSavvy.ai notes that the acquisition of a 5% stake by FMR LLC in Bio-Techne Corp is a significant event, as FMR LLC is a major global investment management firm. Such filings often precede or coincide with shifts in institutional investor sentiment or strategic interest in a company within the biotechnology and life sciences sector.

Stakeholder Impact

• Shareholders: The increased institutional ownership by FMR LLC may lead to greater scrutiny and potential influence on corporate strategy, which could impact shareholder value.
• Management: Bio-Techne Corp's management may face increased engagement from FMR LLC regarding corporate governance and strategic direction.
• Competitors: Competitors may view this stake as a sign of institutional confidence in Bio-Techne Corp's market position and growth potential.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to report any changes in their beneficial ownership of Bio-Techne Corp's common stock as required by SEC regulations.

Key Dates

Keywords

Bio-Techne Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Investor